OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: University of Southern California

6 Projects | 3 Researchers | $2,513,930 Invested

2018

University of Southern California

Hussein Yassine, MD

Effect of early supplementation with high dose DHA on cognitive outcomes in APOE4 carriers: "PreventE4 Trial"

  • Funding Amount: $1,750,483
  • Organization Type: Academic/Nonprofit
  • Program: Prevention
  • Target: APOE
  • Status: Closed

2016

University of Southern California

Justin Ichida, PhD

A novel neuroprotective compound targeting endogenous function of C9ORF72 in vivo

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Other
  • Status: Closed

2015

University of Southern California

Roberta Diaz Brinton, PhD

Allopregnanolone Phase 1 to Phase 2 Acceleration Project

  • Funding Amount: $338,788
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Neuronal Regeneration and Repair
  • Status: Closed

2007

University of Southern California

Roberta Diaz Brinton, PhD

Allopregnanolone as a Neurogenic Factor for Recovery of Neurons in Alzheimer's Disease

  • Funding Amount: $56,998
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuronal Regeneration and Repair
  • Status: Closed

2006

University of Southern California

Roberta Diaz Brinton, PhD

Allopregnanolone as a Neurogenic Factor for Recovery of Neurons in Alzheimer's Disease

  • Funding Amount: $95,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuronal Regeneration and Repair
  • Status: Closed

2004

University of Southern California

Roberta Diaz Brinton, PhD

Allopregnanolone as a Neurogenic Factor for Recovery of Neurons in Alzheimer's Disease

  • Funding Amount: $122,661
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuronal Regeneration and Repair
  • Status: Closed